Emcure Pharmaceuticals To Launch Lizuvira
[email protected]13 Jan, 2022News
Pune, Dec 31 (UNI) Pharma major Emcure Pharmaceuticals Ltd (EPL) said it has received an Emergency Use Authorisation (EUA) approval from the Drug Controller General of India to launch Molnupiravir, an investigational oral anti-viral drug, for the treatment of mild Covid-19.
Related Bookmarks
- Namita Thapar Biography, Net Worth, Early Life, Career, Family
- Cultivators� Notes For Dolato Cannabis Strain
- 3 Expected Pharmaceutical IPOs In 2022
- Onsite Position in dallas & Good Employee Benefits in dallas & Immigration Sponsor in dallas
- Sell Old Vinyl Records Online
- What is the Worth of a Moving Company in St. Catharines?
- H1B Sponsor in dallas & KBK IT Services
- GC Sponsor in dallas & KBK IT Services H1B Sponsor in dallas
- A Pocket Guide To The Mango Kush Cannabis Strain
- Immediate Placement in dallas & GC Sponsor in dallas & KBK IT Services & H1B Sponsor in dallas
Recent Profiles
Hbbet
Fb88 Pvip
Hot Shot Electric
Canglow Windows And Doors
Bert Barr
Fine Book Publishers
Fairhaven Painting | Interior & Exterior Painters
Startbet Br Com
Magicjili Online Gaming
Sriz Screens